MAC
54
-3
SYF
79
-2
PRU
54
-8
DNB
52
2
PFG
50
-3
FAST
56
-3
NWL
39
-9
PX
72
-4
ETR
80
5
MO
59
2
PFE
43
10
WYNN
42
-6
PYPL
81
2
ADBE
61
-3
ACN
58
2
MCO
75
-2
CMG
48
-2
OXY
45
-3
WFC
80
-2
BRK.B
33
-3
MAC
54
-3
SYF
79
-2
PRU
54
-8
DNB
52
2
PFG
50
-3
FAST
56
-3
NWL
39
-9
PX
72
-4
ETR
80
5
MO
59
2
PFE
43
10
WYNN
42
-6
PYPL
81
2
ADBE
61
-3
ACN
58
2
MCO
75
-2
CMG
48
-2
OXY
45
-3
WFC
80
-2
BRK.B
33
-3
Financhill
Back

Sarepta Therapeutics 10K Form

Sell
50

SRPT
Sarepta Therapeutics

Last Price:
$40.42
Seasonality Move:
8.47%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive SRPT News And Ratings

See the #1 stock for the next 7 days that we like better than SRPT

SRPT Financial Statistics

Sales & Book Value

Annual Sales: $1.9B
Cash Flow: $-629.3M
Price / Cash Flow: 0
Annual Sales: $11.63
Price / Book: 3.44

Profitability

EPS (TTM): -2.69000
Net Income (TTM): $-248.4M
Gross Margin: $1.6B
Return on Equity: -20.94%
Return on Assets: -7.03%

Sarepta Therapeutics Earnings Forecast

Key Sarepta Therapeutics Financial Ratios

  • The Gross Profit Margin over the past 29 years for SRPT is 83.22%.
  • The Selling, General & Administrative Expenses for SRPT have been equal to 29.33% of Gross Profit Margin.
  • The Research & Development expenses have been 42.30% of Revenue.
  • The Interest Expense is 7.82% of Operating Income.
  • The Net Earning history of SRPT is 12.37% of Total Revenues.
  • Per Share Earnings over the last 29 years have been positive in 15 years.

Sarepta Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: SRPT
CUSIP: 803607
Website: sarepta.com

Debt

Debt-to-Equity Ratio: 1
Current Ratio: 4.02
Quick Ratio: 2.06

Price-to-Earnings

Trailing P/E Ratio: 17.09
Forward P/E Ratio: 5.1

SRPT Technical Analysis vs Fundamental Analysis

Sell
50
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy or a Sell?